Dow has delivered a strong 37.2% return over the past year, even as the share price has pulled back in recent weeks, which raises a simple question for you as an investor. Is the current US$29.03 price still supported by what the company generates in sales, or has sentiment moved ahead of the underlying revenue base?
The stock’s next move may depend on whether today’s valuation can be explained by its sales, once you compare Dow’s trading multiple against the Fair Ratio benchmark.
If you want to stress test whether Dow’s recent 37.2% one year gain and current sales based valuation question also shows up elsewhere, scan a wider set of 42 high quality undervalued stocks
.P/S is a useful lens for Dow because chemicals producers often trade more on the reliability and pricing of their sales base than on any single year of earnings. On that measure, the stock changes hands at about 0.5x sales, which is well below both the broader chemicals industry at 1.0x and the identified peer group at roughly 1.2x. Against the Fair Ratio benchmark, which adjusts for Dow’s own margin profile, scale and risk, the current P/S also screens on the low side, so the share price aligns more with a discount rather than a premium on this yardstick.
Recent attention around Jim Fitterling’s US$25 million cancer research gift and his comments on tariffs may keep Dow in the headlines, yet the subdued 0.5x P/S still prices the business below what many investors pay for similar revenue streams. For anyone tracking whether the past year’s gain has already used up the value case, this gap on sales is an important piece of the puzzle to weigh. Explore the numbers behind Dow's P/S valuation.
Dow’s Simply Wall St Narratives pick up where the P/S puzzle leaves off. Each scenario spells out the growth, margin and earnings paths that would need to hold for the stock to be worth materially more or less than today’s price. It does this on the Community page so you can see the moving parts behind any fair value and compare those expectations with Dow’s reported results over time.
One of the top narratives on Dow: 16% undervalued
This Narrative is the analyst consensus Narrative on Simply Wall St, which compiles analysts' consensus price target and revenue and earnings forecasts, not one person's view.
"The current valuation implies the share price does not fully reflect this narrative, which views Dow as undervalued and suggests that its structural self-help and capital project delivery could support a higher earnings base over time…"
Discover why this Narrative puts Dow at 16% undervalued.
The next question is who is steering Dow, how their incentives line up with long term value, and whether that pay structure truly supports your thesis. See who runs Dow and how they are paid.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com